Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04740047 · ClinicalTrials.gov registry record
Cios Mobile 3D Spin for Robotic Bronchoscopy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 38
- Enrollment target
NCT04740047: Completed study, sponsored by Mayo Clinic.
NCT04740047 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04740047 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Evaluate the clinical utility and early performance of the Cios 3D Mobile Spin in conjunction with the Ion Endoluminal System, to visualize and facilitate the sampling of pulmonary nodules between 1-3 cm via the airway.
Primary Outcome
Ability to visualize on 3D imaging the pre-planned target location characterized when displayed distance of catheter tip to nearest edge of the virtual target is ≤ 2cm and is oriented towards the lesion in 3 axes.
Interventions
- DIAGNOSTIC_TEST Ion Endoluminal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-05-22 |
What the finished NCT04740047 record still lists
NCT04740047 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ion Endoluminal System is the first listed.
NCT04740047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04740047 about?
NCT04740047 is a clinical study titled "Cios Mobile 3D Spin for Robotic Bronchoscopy". Evaluate the clinical utility and early performance of the Cios 3D Mobile Spin in conjunction with the Ion Endoluminal System, to visualize and facilitate the sampling of pulmonary nodules between 1-3 cm via the airway.
What is the current status of trial NCT04740047?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2021-02-01. Estimated completion is 2023-05-22.
What interventions are being tested in trial NCT04740047?
The interventions under investigation include: Ion Endoluminal System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04740047?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI